STRS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
STRS is not a good buy right now. The chart is in a strong short-term upswing (bullish moving averages and expanding positive MACD), but it is also clearly overbought (RSI_6 ~80) and trading near/above nearby resistance (R1 29.215; post-market ~29.67, with R2 ~30.233). With no proprietary buy signals today and weak/volatile fundamentals in the latest quarter, the risk-reward for an impatient entry is unfavorable at this level.
Trend & momentum: Bullish trend structure (SMA_5 > SMA_20 > SMA_200) with a positive, expanding MACD histogram (0.251), indicating upward momentum is still present.
Overbought condition: RSI_6 at ~80.33 signals an overbought regime—historically this increases odds of a near-term pullback or chop rather than a clean continuation.
Key levels: Pivot 27.569. Resistance at R1 29.215 has effectively been exceeded in post-market (~29.67), with next resistance at R2 30.233. Support levels: S1 25.923 and S2 24.905. From a tactical standpoint, buying here is chasing close to resistance while overbought.
Pattern-based outlook: Similar-pattern stats suggest modest upside probabilities (next day +0.8%, next week +4.97%) but slightly negative 1-month expectation (-0.76%), consistent with “near-term momentum but stretched.”
Intellectia Proprietary Trading Signals
Technical momentum remains positive (bullish MAs, expanding positive MACD), which can support continued short-term strength.
Upcoming earnings: Next earnings scheduled 2026-02-11 (pre-market), which can act as a catalyst for a re-rating if results surprise positively.
while price is pressing into the next resistance zone (~30.23), making an immediate entry less attractive.
Latest quarter: 2025/Q3. Revenue: $4.969M, down -44.11% YoY (clear top-line contraction). Net income: -$4.978M (still a loss) but improved YoY (up 1267.58% in the provided comparison base). EPS: -0.62, improved YoY (+1140%) but remains negative. Gross margin: -43.37 (negative and worse YoY), indicating significant profitability pressure. Overall: despite YoY improvement in loss metrics, the quarter reflects weak demand/realization (revenue down sharply) and stressed profitability (negative gross margin), not the kind of fundamentals that typically justify chasing an overbought rally.
No analyst rating or price target change data was provided, so a Wall Street pros/cons trend assessment cannot be confirmed from this dataset. From the available fundamentals, the main 'pro' case would be any future stabilization/asset monetization and improving loss metrics; the 'con' case is the steep revenue decline and negative gross margin, which usually suppress valuation support.
